---
title: BioAscent Discovery vs PozeSCAF Inc.
slug_a: bioascent-discovery
slug_b: pozescaf-discovery-solutions
site: cro
review_signal_gate: closed
canonical_path: /compare/bioascent-discovery/pozescaf-discovery-solutions
---

# BioAscent Discovery vs PozeSCAF Inc.

Side-by-side profile data from each company listing on this directory.

## BioAscent Discovery

- Profile: [/companies/bioascent-discovery](/companies/bioascent-discovery)

BioAscent Discovery — BioAscent is an integrated drug discovery CRO offering medicinal and synthetic chemistry, computational chemistry, biochemical and biophysical assay development, high-throughput screening, DMPK, flow cytometry, and compound management services to biotech and pharma clients globally.

Services: 8. Modalities: 0. Indications: 2. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Flow Cytometry Services

### Modalities

- Data not yet provided.

### Indications

- Immunology
- Neurology

### Phases

- Discovery

### Sourcing models

- Data not yet provided.

## PozeSCAF Inc.

- Profile: [/companies/pozescaf-discovery-solutions](/companies/pozescaf-discovery-solutions)

PozeSCAF Inc. — Preclinical drug discovery CRO combining proprietary generative AI platform AxDrug with computational chemistry, synthetic chemistry, and in vitro biology to accelerate hit discovery and lead optimization for biotech and pharma clients.

Services: 5. Modalities: 3. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)
- Peptide

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Full-Service Outsourcing (FSO)